The self-renewal of liver cancer stem cells (LCSCs) was characterized by increased expression of toll-like receptor 4 (TLR4), which led to CDDP, 5-FU, and DOX resistance in HCC [78]. This evidence concerns the gene TLR4 and hepatocellular carcinoma.